Announcing the 2020 HBA Board of Directors and Nominating Committee Leadership

As the Healthcare Businesswomen's Association (HBA) works to close out a busy and successful 2019, we are proud to announce the leaders who will guide the organization in the new year.
 
The 2020 HBA board of directors and nominating committee were confirmed today at the HBA’s annual business meeting. These individuals will ensure the organizational focus, strategies and plans are aligned to accelerate the HBA’s mission. The generous donation of time and talent from board members enables the HBA to keep our strategies fresh and relevant while maintaining a laser focus on the longer-term goal of gender parity at all levels of leadership.

2020 HBA Global Board of Directors 

Executive committee:

  • Chair: Rebecca Vermeulen RPH, head of customer strategy and patient partnership for global medical affairs, Roche
  • Vice-chair: Simona King, VP, finance and assistant treasurer, Emergent BioSolutions
  • Secretary/treasurer: Angela Gillespie, president, W2O wcg
  • President and CEO: Laurie Cooke RPH, president and CEO, HBA (ex-officio, non-voting)

Directors at large:

  • Adam Dubow, senior vice president and chief compliance and ethics officer, Bristol-Myers Squibb Company
  • Erik D. Smith, PhD, principal, strategy and analytics, Deloitte Consulting
  • Gisela A. Paulsen, MPharm, SVP, global head, product development clinical operations, Roche/Genentech
  • Jaime Marks Corvino, associate director, account management, KPMG LLP (non-voting)
  • Jhaymee Tynan, assistant VP, integration, Atrium Health (non-voting)
  • Julie Ross, president, Advanced Clinical
  • Laura Butler, CEO, WorkLife Consulting, LLC (chair, Council of Chapter Presidents)
  • La'Wana Harris, global diversity consultant, La'Wana Harris Inc
  • Liz Paulson, strategic account executive, LexisNexis 
  • Rita Ribeiro, senior director of marketing and communications

2020 HBA Nominating Committee

  • Chair: Shannon Resetich, head of North America rare disease and rare blood disorders, Sanofi Genzyme
  • Joe DePinto, president, Cardinal Health Specialty Solutions
  • June Zeringue, consultant, Insigniam 
  • Melissa McLaughlin, SVP, HR/chief people officer, Agios Pharmaceuticals, Inc.
  • Stefania Migliuolo, founder and CEO, Alecrìa

The incoming directors are inspired with their charge to continue the great work of the 2019 board, to champion the HBA’s mission of furthering the advancement and impact of women in the business of healthcare.

We are grateful and appreciative for the service of the 2019 HBA board of directors and nominating committee members – those continuing their terms in 2020, and those committed advocates completing their terms this year. 

Thank you to the 2019 HBA board of directors:

Executive committee:

  • Chair: Rebecca Vermeulen RPH, head of customer strategy and patient partnership for global medical affairs, Roche
  • Vice-chair: Simona King, VP, finance and assistant treasurer, Emergent BioSolutions
  • Secretary/treasurer: Angela Gillespie, president, W2O wcg
  • President and CEO: Laurie Cooke RPH, president CEO, HBA (ex-officio, non-voting)

Directors at large:

  • Erik D. Smith, PhD, principal, strategy and analytics, Deloitte Consulting
  • Jaime Marks Corvino, associate director, account management, KPMG LLP (non-voting)
  • Julie Ross, president, Advanced Clinical
  • Kim Fox, communications leader, office of the chief medical officer, Johnson & Johnson
  • La'Wana Harris, global diversity consultant, La'Wana Harris Inc
  • Liz Paulson, strategic account executive, LexisNexis (chair, Council of Chapter Presidents)
  • Ozge Saritosun Kurtoglu, VP, pricing strategy and insights, Pearson Corporation
  • Rita Ribeiro, senior director of marketing and communications

Thank you to the 2019 nominating committee:

  • Chair: Shannon Resetich, head of North America rare disease and rare blood disorders, Sanofi Genzyme
  • Joe DePinto, president, Cardinal Health Specialty Solutions
  • June Zeringue, consultant, Insigniam
  • Lisa George, chief human resources officer, Shearer’s Snacks
  • Quita Highsmith, head of alliance and advocacy relations, Genentech, Inc., A Member of the Roche Group